Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Diabetes|August 1, 1985
Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuriaJ J Bending, G C Viberti, R W Bilous, et al.
British Medical Journal (Clinical Research Ed.)|January 11, 1986
Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic controlJ J Bending, G C Viberti, P J Watkins, et al.
The New England Journal of Medicine|March 22, 1979
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetesG C Viberti, J C Pickup, R J Jarrett, et al.
British Medical Journal (Clinical Research Ed.)|March 7, 1981
Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusionJ C Pickup, H Keen, G C Viberti, et al.
British Medical Journal (Clinical Research Ed.)|October 22, 1983
Severe diabetic microangiopathy with normal glucose tolerance and pituitary infarctionR W Bilous, R N Poston, H Keen, et al.
Diabetes|May 1, 1988
Proteinuria and activated T-lymphocytes in diabetic nephropathyJ J Bending, A Lobo-Yeo, D Vergani, et al.
Diabetologia|October 1, 1985
The glomerular hyperfiltration of diabetes is not associated with elevated plasma levels of glucagon and growth hormoneM J Wiseman, S Redmond, F House, et al.
European Journal of Clinical Investigation|April 1, 1991
Effect of low protein diet on the renal response to meat ingestion in diabetic nephropathyJ R Pinto, J J Bending, R A Dodds, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1989
Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitusG C Viberti, A Benigni, E Bognetti, et al.
British Journal of Clinical Pharmacology|April 1, 1987
Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336)A E Pontiroli, G C Viberti, R Mangili, et al.
Pageof 21